Playback speed
10 seconds
This video is featured in the 2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: ARROS-1 Study - Zidesamtinib in Advanced ROS1 Fusion-Positive NSCLC and Other Solid Tumors
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Benjamin Besse
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Benjamin Besse
37 views
October 1, 2024
Comments 0
Login to view comments.
Click here to Login